ZLDAF
Zelira Therapeutics Limited

29
Mkt Cap
$2.78M
Volume
157.00
52W High
$0.3832
52W Low
$0.20
PE Ratio
-1.13
ZLDAF Fundamentals
Price
$0.2334
Prev Close
$0.20
Open
$0.2334
50D MA
$0.2163
Beta
0.10
Avg. Volume
530.47
EPS (Annual)
-$0.2046
P/B
-0.95
Loading...
Loading...
Zelira Therapeutics Ltd. is a bio-pharmaceutical company, which engages in the research, development and commercialisation of cannabinoid-based formulations for the treatment of a variety of medical conditions. It operates through the following geographical segments: Australia and USA. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Zelira Therapeutics Limited?
What is the 52-week high for Zelira Therapeutics Limited?
What is the 52-week low for Zelira Therapeutics Limited?
What is Zelira Therapeutics Limited stock price today?
What was Zelira Therapeutics Limited stock price yesterday?
What is the PE ratio of Zelira Therapeutics Limited?
What is the Price-to-Book ratio of Zelira Therapeutics Limited?
What is the 50-day moving average of Zelira Therapeutics Limited?

Latest ZLDAF News

View
No ZLDAF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.